These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22996959)

  • 1. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies.
    Whiteley WN; Slot KB; Fernandes P; Sandercock P; Wardlaw J
    Stroke; 2012 Nov; 43(11):2904-9. PubMed ID: 22996959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.
    AbdelRazek MA; Mowla A; Hojnacki D; Zimmer W; Elsadek R; Abdelhamid N; Elsadek L; Farooq S; Kamal H; Crumlish A; Shirani P; Ching M; Sawyer R
    Cerebrovasc Dis; 2015; 40(5-6):201-4. PubMed ID: 26402147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
    Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
    Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke.
    Dharmasaroja PA; Muengtaweepongsa S; Pattaraarchachai J; Dharmasaroja P
    J Clin Neurosci; 2012 Jun; 19(6):799-803. PubMed ID: 22472785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
    Wardlaw JM; Sandercock PA; Berge E
    Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study.
    Karaszewski B; Gójska-Grymajło A; Czaplewska P; Jabłoński B; Lewandowska AE; Ossowska D; Wyszomirski A; Hałas M; Szurowska E
    Sci Rep; 2021 Sep; 11(1):18765. PubMed ID: 34548538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V; von Kummer R R; Müller A; Bluhmki E
    Stroke; 2001 Feb; 32(2):438-41. PubMed ID: 11157179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage.
    Teekaput C; Thiankhaw K; Tanprawate S; Teekaput K; Chai-Adisaksopha C
    PLoS One; 2022; 17(8):e0272257. PubMed ID: 35913922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
    Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
    Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic thrombolysis in acute ischemic stroke patients with unruptured intracranial aneurysms.
    Goyal N; Tsivgoulis G; Zand R; Sharma VK; Barlinn K; Male S; Katsanos AH; Bodechtel U; Iftikhar S; Arthur A; Elijovich L; Alexandrov AW; Alexandrov AV
    Neurology; 2015 Oct; 85(17):1452-8. PubMed ID: 26408492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
    Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
    Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.
    Cucchiara B; Tanne D; Levine SR; Demchuk AM; Kasner S
    J Stroke Cerebrovasc Dis; 2008; 17(6):331-3. PubMed ID: 18984422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
    Cucchiara B; Kasner SE; Tanne D; Levine SR; Demchuk A; Messe SR; Sansing L; Lees KR; Lyden P;
    Stroke; 2009 Sep; 40(9):3067-72. PubMed ID: 19608993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Risk Factors in Thrombolysis therapy: Telestroke Versus Nontelestroke.
    Nathaniel TI; Gainey J; Blum B; Montgomery C; Ervin L; Madeline L
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2524-2533. PubMed ID: 29859864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke.
    Dorňák T; Král M; Sedláčková Z; Šaňák D; Čecháková E; Divišová P; Zapletalová J; Kaňovský P
    Transl Stroke Res; 2018 Dec; 9(6):582-588. PubMed ID: 29333567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
    Yang Y; Liu B; Wu L; Guan X; Luo Y; Jiang C; Gupta S; Huang Z; Everett G
    Cerebrovasc Dis; 2019; 48(3-6):157-164. PubMed ID: 31694030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.